Clinical Trials Logo

Partial Epilepsy clinical trials

View clinical trials related to Partial Epilepsy.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT04513860 Approved for marketing - Partial Epilepsy Clinical Trials

Cenobamate Expanded Access Program (EAP)

Start date: n/a
Phase:
Study type: Expanded Access

This Cenobamate Expanded Access Program (EAP) is designed to continue providing treatment with Cenobamate (YKP3089) to patients with partial-onset epilepsy that were enrolled in the SK Life Science clinical trial YKP3089C013, YKP3089C017 or YKP3089C021.